EUVIMEDEUVIMED entdecken
Crossref

Gut microbiota-derived ergothioneine alleviates antipsychotic-induced synaptic and cognitive impairments

Mingxuan Zheng, Hanrong Yan, Wenting Hao, Huimei An, Xi Chen, Qingyuan Wu, Xing Ge, Huaiyu Ye, Menglu Zhou, Guorong Zhou, Xiaoying Yang, Minmin Hu und 6 weitere

Cell Host & Microbe · 2026-05 · 34 (5) · 959-974.e7

DOI: 10.1016/j.chom.2026.03.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2026-05. Verfasst von Mingxuan Zheng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Im…. Hauptthemen laut MEDLINE: Ergothioneine, Antipsychotic Agents, Gastrointestinal Microbiome, Cognitive Dysfunction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Natural Science Research of Jiangsu Higher Education Institutions of China, Jiangsu Province Natural Science Foundation, Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic antipsychotic use is associated with neuronal damage and cognitive impairment, with the gut microbiome increasingly implicated. However, the specific microbial metabolites and mechanisms involved remain unknown. Here, we demonstrate that chronic olanzapine treatment induces gut microbial dysbiosis, compromises intestinal barrier integrity, and causes cognitive deficits in mice. Multi-omics analyses reveal profound depletion of the microbiota-associated metabolite ergothioneine in blood and brain, a finding validated in the blood of olanzapine-treated patients and risperidone- and clozapine-treated mice. This deficiency correlates with a loss of ergothioneine-producing bacteria (Cyanobacteria and subordinate taxa). Fecal microbiota transplantation from olanzapine-treated mice confers cognitive impairment, while ergothioneine supplementation mitigates it. Mechanistically, ergothioneine attenuates hippocampal oxidative stress and inhibits the redox-sensitive phosphatase protein tyrosine phosphatase 1B (PTP1B). Furthermore, hippocampal neuronal-specific PTP1B deletion abolishes olanzapine-induced synaptic and cognitive deficits. Our findings identify depletion of microbiota-derived ergothioneine as a mechanism underlying antipsychotic-induced cognitive impairment, highlighting therapeutic strategies to mitigate this side effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErgothioneineAntipsychotic AgentsGastrointestinal MicrobiomeCognitive DysfunctionAnimalsMiceOlanzapineProtein Tyrosine Phosphatase, Non-Receptor Type 1HippocampusHumansDysbiosisOxidative StressFecal Microbiota TransplantationMaleMice, Inbred C57BL

Stichwörter der Autor:innen

CyanobacteriaPTP1Bantipsychoticscognitive impairmentergothioneinegut-brain axisolanzapine

Substanzen

ErgothioneineAntipsychotic AgentsOlanzapineProtein Tyrosine Phosphatase, Non-Receptor Type 1Ptpn1 protein, mouse

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; De…
  • Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China.
  • HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Peking University, Beijing 10096, China.
  • Illawarra Health and Medical Research Institute (IHMRI) and School of Medicine, University of Wollongong, Wollongong, NSW 2522, Australia.
  • National Experimental Demonstration Center for Basic Medicine Education, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; The First Clinical Medical College, Xuzhou Medical University, Xuzhou 221004, China.
  • Jiangsu Key Laboratory of Immunity and Metabolism, Jiangsu International Laboratory of Immunity and Metabolism, Department of Pathogen Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China; Na…

Förderung

  • Natural Science Research of Jiangsu Higher Education Institutions of China
  • Jiangsu Province Natural Science Foundation
  • Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions
  • Xuzhou Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Zheng, M., Yan, H., Hao, W., An, H., Chen, X., Wu, Q., Ge, X., Ye, H., Zhou, M., Zhou, G., Yang, X., Hu, M., Zhang, P., Pan, W., Tang, R., Zheng, K., Huang, X. F., & Yu, Y. (2026). Gut microbiota-derived ergothioneine alleviates antipsychotic-induced synaptic and cognitive impairments. Cell Host & Microbe, 34(5), 959-974.e7. https://doi.org/10.1016/j.chom.2026.03.020

Vancouver

Zheng M, Yan H, Hao W, An H, Chen X, Wu Q, et al. Gut microbiota-derived ergothioneine alleviates antipsychotic-induced synaptic and cognitive impairments. Cell Host & Microbe. 2026;34(5):959-974.e7. doi:10.1016/j.chom.2026.03.020

BibTeX
@article{Zheng2026,
  author = {Zheng, Mingxuan and Yan, Hanrong and Hao, Wenting and An, Huimei and Chen, Xi and Wu, Qingyuan and Ge, Xing and Ye, Huaiyu and Zhou, Menglu and Zhou, Guorong and Yang, Xiaoying and Hu, Minmin and Zhang, Peng and Pan, Wei and Tang, Renxian and Zheng, Kuiyang and Huang, Xu-Feng and Yu, Yinghua},
  title = {Gut microbiota-derived ergothioneine alleviates antipsychotic-induced synaptic and cognitive impairments},
  journal = {Cell Host & Microbe},
  year = {2026},
  volume = {34},
  number = {5},
  pages = {959--974.e7},
  doi = {10.1016/j.chom.2026.03.020}
}
Kostenlos starten →